In contrast, ERMS tumors commonly harbor loss of heterozygosity at 11p15.5 [5] as well as point mutations in TP53[6], NRAS, KRAS, HRAS[7], PIK3CA[8] and FGFR4[9] genes. Here, FGFR4 is linked to embryonal rhabdomyosarcoma.